Overview
Cat #: BLP-DR001
Type: Synthetic peptide
Form: Lyophilized powder
D1 Dopamine Receptor Blocking Peptide (#BLP-DR001) is the original antigen used for immunization during Anti-D1 Dopamine Receptor Antibody (#ADR-001) generation. The blocking peptide binds and ‘blocks’ Anti-D1 Dopamine Receptor primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
Applications: wb, ihc
Application key:
WB- Western blot, IHC- Immunohistochemistry
For research purposes only. not for human use
Applications
Demonstration of Pre-adsorption control
- Western blot analysis of mouse (lanes 1 and 3) and rat (lanes 2 and 4) brain lysates:1,2. Anti-D1 Dopamine Receptor Antibody (#ADR-001), (1:200).
3,4. Anti-D1 Dopamine Receptor Antibody, preincubated with D1 Dopamine Receptor Blocking Peptide (#BLP-DR001). - Expression of DRD1 in rat cortexImmunohistochemical staining of perfusion-fixed frozen brain sections with Anti-D1 Dopamine Receptor Antibody (#ADR-001), (1:100), (green). A. DRD1 appears in the soma and dendrites of cortical pyramidal neurons in layer 5. B. The same section was stained for Calbindin D28k (red), a marker of interneurons. C. Merging of the two images demonstrates that localization of DRD1 is restricted to pyramidal neurons. DAPI is used as the counterstain.
- Expression of DRD1 in rat striatumImmunohistochemical staining of perfusion-fixed frozen brain sections with Anti-D1 Dopamine Receptor Antibody (#ADR-001), (1:100), (green). A. DRD1 appears in the striatal matrix (star). B. The same section was stained for Calbindin D28k (red), a marker of interneurons. C. Merging of the two images demonstrates that localization of DRD1 is restricted to the matrix. DAPI is used as the counterstain.
- Western blot analysis of rat brain synaptosomal fraction (lanes 1 and 3) and mouse brain synaptosomal fraction (lanes 2 and 4):1,2. Guinea pig Anti-D1 Dopamine Receptor Antibody (#ADR-001-GP), (1:400).
3,4. Guinea pig Anti-D1 Dopamine Receptor Antibody, preincubated with D1 Dopamine Receptor Blocking Peptide (#BLP-DR001). - Western blot analysis of human SH-SY5Y neuroblastoma cell lysate:
1. Guinea pig Anti-D1 Dopamine Receptor Antibody (#ADR-001-GP), (1:400).
2. Guinea pig Anti-D1 Dopamine Receptor Antibody, preincubated with D1 Dopamine Receptor Blocking Peptide (#BLP-DR001). - Expression of DRD1 in rat cortexImmunohistochemical staining of perfusion-fixed frozen rat brain sections using Guinea pig Anti-D1 Dopamine Receptor Antibody (#ADR-001-GP), (1:300), followed by goat-anti-guinea pig-Cy3 antibody. DRD1 staining (red) appears in neuronal soma (arrows). Nuclei are stained with DAPI (blue).
Properties
Sequence
- SSHHEPRGSISKDC, corresponding to amino acid residues 372-385 of rat DRD1 (Accession P18901).
Accession (Uniprot) Number P18901
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Purity >70%
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.